NYSE:AZN - AstraZeneca Stock Price, Forecast & News

AstraZeneca's stock was trading at $44.58 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, AZN stock has decreased by 0.5% and is now trading at $44.37. View which stocks have been mosted impacted by Coronavirus.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AstraZeneca in the last year. There are currently 2 sell ratings, 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for AstraZeneca.

AstraZeneca is scheduled to release its next quarterly earnings announcement on Friday, April 24th 2020. View our earnings forecast for AstraZeneca.

AstraZeneca plc (NYSE:AZN) issued its quarterly earnings data on Friday, February, 14th. The company reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.53 by $0.08. The business had revenue of $6.66 billion for the quarter, compared to analyst estimates of $6.75 billion. AstraZeneca had a net margin of 5.38% and a return on equity of 32.24%. The firm's revenue was up 3.8% on a year-over-year basis. During the same period last year, the firm earned $1.58 earnings per share. View AstraZeneca's earnings history.

AstraZeneca announced a semi-annual dividend on Tuesday, February 18th. Investors of record on Friday, February 28th will be paid a dividend of $0.95 per share on Monday, March 30th. This represents a dividend yield of 2.8%. The ex-dividend date of this dividend is Thursday, February 27th. View AstraZeneca's dividend history.

AstraZeneca's stock split on Monday, July 27th 2015. The 2-1 split was announced on Friday, June 26th 2015. The newly created shares were payable to shareholders after the market closes on Friday, July 24th 2015. An investor that had 100 shares of AstraZeneca stock prior to the split would have 200 shares after the split.

6 Wall Street analysts have issued 12-month target prices for AstraZeneca's stock. Their forecasts range from $40.73 to $55.00. On average, they anticipate AstraZeneca's share price to reach $48.58 in the next twelve months. This suggests a possible upside of 9.5% from the stock's current price. View analysts' price targets for AstraZeneca.

News articles about AZN stock have trended very positive this week, InfoTrie reports. InfoTrie rates the sentiment of press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. AstraZeneca earned a daily sentiment score of 3.2 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news aboutAstraZeneca.

AstraZeneca saw a decline in short interest in the month of March. As of March 13th, there was short interest totaling 7,174,500 shares, a decline of 20.0% from the February 27th total of 8,970,000 shares. Based on an average trading volume of 3,080,000 shares, the short-interest ratio is presently 2.3 days. Approximately 0.3% of the company's stock are sold short. View AstraZeneca's Current Options Chain.

Some companies that are related to AstraZeneca include Johnson & Johnson (JNJ), Roche Holdings AG Basel (RHHBY), Merck & Co., Inc. (MRK), Novartis (NVS), Pfizer (PFE), Novo Nordisk A/S (NVO), Abbott Laboratories (ABT), Eli Lilly And Co (LLY), Bristol-Myers Squibb (BMY), AbbVie (ABBV), Sanofi (SNY), GlaxoSmithKline (GSK), Commonwealth Bank of Australia (CSLLY), Celgene (CELG) and Allergan (AGN).

Based on aggregate information from My MarketBeat watchlists, some companies that other AstraZeneca investors own include Pfizer (PFE), AT&T (T), AbbVie (ABBV), Bank of America (BAC), Gilead Sciences (GILD), Cisco Systems (CSCO), Micron Technology (MU), Merck & Co., Inc. (MRK), Bristol-Myers Squibb (BMY) and NVIDIA (NVDA).

AstraZeneca trades on the New York Stock Exchange (NYSE) under the ticker symbol "AZN."

Shares of AZN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of AZN stock can currently be purchased for approximately $44.37.

AstraZeneca has a market capitalization of $116.44 billion and generates $24.38 billion in revenue each year. The company earns $1.34 billion in net income (profit) each year or $1.75 on an earnings per share basis. AstraZeneca employs 64,400 workers across the globe. View additional information about AstraZeneca.

The official website for AstraZeneca is http://www.astrazeneca.com/.

AstraZeneca's mailing address is 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS, CAMBRIDGE X0, CB2 0AA. The company can be reached via phone at 44-20-3749-5000 or via email at [email protected]